Jonathan B. Rothbard

Jonathan B. Rothbard's AcademicInfluence.com Rankings

Philosophy

#8815

World Rank

#12268

Historical Rank

Logic

#5830

World Rank

#7271

Historical Rank

philosophy Degrees

Jonathan B. Rothbard

Biology

#11998

World Rank

#15443

Historical Rank

Virology

#288

World Rank

#295

Historical Rank

Immunology

#790

World Rank

#813

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Jonathan B. Rothbard's Degrees

Doctorate Medicine Stanford University

Why Is Jonathan B. Rothbard Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jonathan B. Rothbard's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides (1986) (1752)
The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. (2000) (1447)
Polyarginine enters cells more efficiently than other polycationic homopolymers. (2000) (980)
Partial T cell signaling: Altered phospho-ζ and lack of zap70 recruitment in APL-induced T cell anergy (1994) (660)
A sequence pattern common to T cell epitopes. (1988) (605)
Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation (2000) (588)
A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. (1988) (554)
Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells. (2004) (538)
T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis (1986) (470)
Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2 (1987) (430)
Selection for T-cell receptor Vβ–Dβ–Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis (1993) (410)
Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle. (1988) (354)
A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes (1989) (338)
Arginine-rich molecular transporters for drug delivery: role of backbone spacing in cellular uptake. (2002) (287)
Differences in the carbohydrate structures of neural cell-adhesion molecules from adult and embryonic chicken brains. (1982) (285)
Adaptive translocation: the role of hydrogen bonding and membrane potential in the uptake of guanidinium-rich transporters into cells. (2005) (276)
Stress proteins may provide a link between the immune response to infection and autoimmunity. (1989) (268)
Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy. (1992) (262)
Peptide binding to HLA‐DR1: a peptide with most residues substituted to alanine retains MHC binding. (1990) (245)
Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands. (1995) (242)
Truncation variants of peptides isolated from MHC class II molecules suggest sequence motifs (1992) (240)
Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2 (2015) (223)
Structure, expression and divergence of T-cell receptor β-chain variable regions (1984) (202)
Interactions between Immunogenic Peptides and MHC Proteins (1991) (200)
Expression of the c‐erbB‐2 protein in normal and transformed cells (1987) (199)
Introduction of soluble proteins into the MHC class I pathway by conjugation to an HIV tat peptide. (1997) (198)
Immunogenicity of synthetic peptides from circumsporozoite protein of Plasmodium falciparum. (1985) (189)
A hypothetical model for the peptide binding domain of hsp70 based on the peptide binding domain of HLA. (1991) (182)
Detection of T cells in paraffin wax embedded tissue using antibodies against a peptide sequence from the CD3 antigen. (1989) (180)
Gonococcal pili. Primary structure and receptor binding domain (1984) (173)
Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. (1998) (172)
Structural model of HLA-DR1 restricted T cell antigen recognition (1988) (167)
Involvement of distinct murine T-cell receptors in the autoimmune encephalitogenic response to nested epitopes of myelin basic protein. (1988) (166)
Predominant expression of a T cell receptor V beta gene subfamily in autoimmune encephalomyelitis [published erratum appears in J Exp Med 1988 Jul 1;168(1):455] (1988) (165)
Use of synthetic peptides of influenza nucleoprotein to define epitopes recognized by class I-restricted cytotoxic T lymphocytes (1987) (158)
Oligocarbamate molecular transporters: design, synthesis, and biological evaluation of a new class of transporters for drug delivery. (2002) (149)
Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401. (1996) (148)
Cloning and sequencing of a Moraxella bovis pilin gene (1985) (146)
Mapping of T cell epitopes using recombinant antigens and synthetic peptides. (1987) (141)
Releasable luciferin-transporter conjugates: tools for the real-time analysis of cellular uptake and release. (2006) (138)
Molecular Transporters: Synthesis of Oligoguanidinium Transporters and Their Application to Drug Delivery and Real‐Time Imaging (2006) (137)
Molecular basis for cytolytic T-lymphocyte recognition of the murine cytomegalovirus immediate-early protein pp89 (1988) (136)
Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB1*0401. (1994) (136)
Enhanced recognition of a modified peptide antigen by cytotoxic T cells specific for influenza nucleoprotein (1988) (133)
HLA-A2 peptides can regulate cytolysis by human allogeneic T lymphocytes (1987) (133)
Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins. (1989) (131)
Interactions between immunogenic peptides and MHC proteins. (1991) (130)
Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces. (1990) (127)
In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes. (1988) (126)
Recognition of influenza A matrix protein by HLA-A2-restricted cytotoxic T lymphocytes. Use of analogues to orientate the matrix peptide in the HLA-A2 binding site (1988) (126)
Systemic augmentation of αB-crystallin provides therapeutic benefit twelve hours post-stroke onset via immune modulation (2011) (125)
Specificity of an HLA‐DRB1*0401‐restricted T cell response to type II collagen (1996) (124)
Idiotype vaccination against murine B cell lymphoma. Humoral and cellular responses elicited by tumor-derived immunoglobulin M and its molecular subunits. (1987) (121)
Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding. (1991) (107)
Antibodies to peptides corresponding to a conserved sequence of gonococcal pilins block bacterial adhesion. (1985) (106)
Structural homologies between two HLA B27-restricted peptides suggest residues important for interaction with HLA B27. (1990) (104)
Prediction of peptide affinity to HLA DRB1*0401. (1994) (101)
Strain-specific and common epitopes of gonococcal pili (1984) (100)
Novel chimaeric protein expressed in Philadelphia positive acute lymphoblastic leukaemia (1987) (96)
Multiple discrete encephalitogenic epitopes of the autoantigen myelin basic protein include a determinant for I-E class II-restricted T cells (1988) (94)
HLA B37 determines an influenza A virus nucleoprotein epitope recognized by cytotoxic T lymphocytes (1986) (93)
Human T cell responses to human papillomavirus type 16 L1 and E6 synthetic peptides: identification of T cell determinants, HLA-DR restriction and virus type specificity. (1990) (90)
A monoclonal antibody recognising the site of limited proteolysis of protein kinase C. Inhibition of down-regulation in vivo. (1988) (88)
Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands. (1994) (86)
Characterization of epitopes recognized by hapten-specific CD4+ T cells. (1995) (83)
A juxta-membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis. (1988) (82)
Therapeutic Effects of Systemic Administration of Chaperone αB-Crystallin Associated with Binding Proinflammatory Plasma Proteins* (2012) (78)
Real-time analysis of uptake and bioactivatable cleavage of luciferin-transporter conjugates in transgenic reporter mice (2007) (77)
Guanidinium rich peptide transporters and drug delivery. (2003) (75)
T-cell reactivity in myasthenia gravis. (1989) (72)
Arginine-based molecular transporters: the synthesis and chemical evaluation of releasable taxol-transporter conjugates. (2003) (71)
Delivery of antimicrobials into parasites (2003) (68)
Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. (1993) (67)
Structural analysis of a peptide--HLA class II complex: identification of critical interactions for its formation and recognition by T cell receptor. (1989) (66)
Amyloid Fibrils Composed of Hexameric Peptides Attenuate Neuroinflammation (2013) (62)
Peptides and the cellular immune response (1986) (59)
Conformational and structural characteristics of peptides binding to HLA-DR molecules. (1991) (59)
Dendrimeric molecular transporters: synthesis and evaluation of tunable polyguanidino dendrimers that facilitate cellular uptake. (2005) (58)
Quantitative analysis of T cell activation: role of TCR/ligand density and TCR affinity. (1996) (58)
Peptide-mediated modulation of T-cell allorecognition. (1988) (58)
αB-crystallin improves murine cardiac function and attenuates apoptosis in human endothelial cells exposed to ischemia-reperfusion. (2011) (57)
Chaperone Activity of Small Heat Shock Proteins Underlies Therapeutic Efficacy in Experimental Autoimmune Encephalomyelitis* (2012) (57)
T cell specificity for class II (I-A) and the encephalitogenic N-terminal epitope of the autoantigen myelin basic protein. (1987) (54)
Pili of Neisseria meningitidis. Analysis of structure and investigation of structural and antigenic relationships to gonococcal pili (1985) (49)
Synthetic peptides as vaccines (1987) (48)
Comparison between two peptide epitopes presented to cytotoxic T lymphocytes by HLA-A2. Evidence for discrete locations within HLA-A2. (1989) (47)
Localisation of islet amyloid peptide in lipofuscin bodies and secretory granules of human B-cells and in islets of type-2 diabetic subjects (1989) (46)
L-arginine polymers inhibit the development of vein graft neointimal hyperplasia. (2001) (46)
Photoreactions of charged benzophenone with amphiphiles in micelles and multicomponent aggregates as conformational probes (1978) (44)
Prediction and identification of an HLA‐DR‐restricted T cell determinant in the 19‐kDa protein of Mycobacteriurn tuberculosis (1988) (43)
Detection of peptide-MHC class II complexes on the surface of intact cells. (1990) (42)
An HIV-1 and HIV-2 cross-reactive cytotoxic T-cell epitope. (1990) (40)
The mycobacterial GroEL stress protein: a common target of T-cell recognition in infection and autoimmunity. (1989) (40)
Amino acid residues 56 to 69 of HLA-A2 specify an antigenic determinant shared by HLA-A2 and HLA-B17. (1986) (39)
All eight unassigned reading frames of mouse mitochondrial DNA are expressed. (1984) (38)
REMOTE FUNCTIONALIZATION REACTIONS AS CONFORMATIONAL PROBES FOR FLEXIBLE ALKYL CHAINS (1978) (38)
Antibodies to synthetic peptides defined by cDNA cloning reveal a network of peptidergic neurons in Aplysia (1984) (36)
The human T3 gamma chain is phosphorylated at serine 126 in response to T lymphocyte activation. (1987) (36)
Structural and functional studies of HLA-DR restricted antigen recognition by human helper T lymphocyte clones by using transfected murine cell lines. (1988) (36)
Reversal of HLA restriction by a point mutation in an antigenic peptide. (1989) (35)
Chaperone Activity of α B-Crystallin Is Responsible for Its Incorrect Assignment as an Autoantigen in Multiple Sclerosis (2011) (34)
Positioning of a peptide in the cleft of HLA-A2 by complementing amino acid changes. (1991) (34)
Structure, expression and divergence of T-cell receptor beta-chain variable regions. (1984) (33)
The autoimmune response of different mouse strains to T-cell epitopes of the human acetylcholine receptor alpha subunit. (1990) (33)
Structure of the heavy chain of the H-2Kk histocompatibility antigen. (1980) (32)
Apparent lack of MHC restriction in binding of class I HLA molecules to solid-phase peptides (1990) (32)
An in vitro model of peptide-mediated immunomodulation of the human T cell response to Dermatophagoides spp (house dust mite). (1991) (31)
Peptides recognized by class I restricted T cells also bind to MHC class II molecules. (1990) (31)
Responses of NOD congenic mice to a glutamic acid decarboxylase-derived peptide. (1994) (26)
Syngeneic antiidiotypic immune responses to a B cell lymphoma. Comparison between heavy chain hypervariable region peptides and intact Ig as immunogens (1985) (26)
DIABETES-ASSOCIATED PEPTIDE (1987) (26)
T-cell recognition of influenza viral antigens. (1987) (26)
Antigenic analysis of gonococcal pili using monoclonal antibodies (1984) (22)
Rapid and Efficient Vascular Transport of Arginine Polymers Inhibits Myointimal Hyperplasia (2000) (21)
Recognition of influenza virus proteins by cytotoxic T lymphocytes. (1989) (20)
Definition of murine T helper cell determinants in the major capsid protein of human papillomavirus type 16. (1990) (19)
Class I MHC molecules rather than other mouse genes dictate influenza epitope recognition by cytotoxic T cells (2004) (19)
Identification of mycobacterial antigens recognized by T lymphocytes. (1989) (18)
Species conservation of the T cell lymphocyte CD2 cell surface antigen (1988) (16)
Inhibition of T cell proliferation specific for acetylcholine receptor epitopes related to myasthenia gravis with antibody to T cell receptor or with competitive synthetic polymers. (1990) (16)
Recruitment of alloreactive cytotoxic T lymphocytes by an antigenic peptide (1989) (16)
CRYAB modulates the activation of CD4+ T cells from relapsing–remitting multiple sclerosis patients (2013) (14)
Mechanisms of action of therapeutic amyloidogenic hexapeptides in amelioration of inflammatory brain disease (2014) (12)
Dephosphorylation of the human T lymphocyte CD3 antigen. (1989) (12)
PREDOMINANT EXPRESSION OF A T CELL RECEPTOR V,6 GENE SUBFAMILY IN AUTOIMMUNE ENCEPHALOMYELITIS (2003) (12)
Janus Faces of Amyloid Proteins in Neuroinflammation (2014) (12)
Synthetic peptides as vaccines. (1987) (12)
Pattern recognition among T-cell epitopes. (1987) (11)
Short polymers of arginine rapidly translocate into vascular cells: effects on nitric oxide synthesis. (2002) (11)
L-arginine polymer mediated inhibition of graft coronary artery disease after cardiac transplantation. (2001) (10)
The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. 1986. (2006) (10)
L-Arginine polymers enhance coronary flow and reduce oxidative stress following cardiac transplantation in rats. (2003) (9)
Major histocompatibility complex-peptide interactions. (1989) (9)
Piet Mondrian’s trees and the evolution in understanding multiple sclerosis, Charcot Prize Lecture 2011 (2013) (9)
Comparison of three different forms of HLA‐DR4Dw4 proteins (1993) (8)
Antigen Presentation: One size fits all (1994) (8)
Differential stability of HLA-DR alleles independent of endogenous peptides. (1995) (7)
Self-Assembling Peptides Form Immune Suppressive Amyloid Fibrils Effective in Autoimmune Encephalomyelitis. (2015) (6)
Experimental strategies to explore the molecular details of MHC-peptide complexes. (1990) (5)
The primary sequence and antigenic structure of gonococcal pilin: approaches towards a gonococcal vaccine. (1985) (5)
Recognition of the HLA class II-peptide complex by T-cell receptor: reversal of major histocompatibility complex restriction of a T-cell clone by a point mutation in the peptide determinant. (1989) (5)
Genetic background modulates outcome of therapeutic amyloid peptides in treatment of neuroinflammation (2016) (4)
Blood and thymic lymphocyte responses to peptide sequences of the acetylcholine receptor in myasthenia gravis (1987) (4)
An amyloidogenic hexapeptide derived from amylin attenuates inflammation and acute lung injury in murine sepsis (2018) (3)
Interactions between immunogenic peptides and HLA-DR molecules (1990) (3)
STRAIN-SPECIFIC AND COMMON EPITOPES OF (1984) (3)
Structural analysis of a peptide-HLA class II complex. (1989) (3)
Quantitation of cellular and topical uptake of luciferin-oligoarginine conjugates. (2011) (2)
Molecular understanding of cellular uptake by arginine-rich cell penetrating peptides (2006) (2)
High Degeneracy of HLA DR-Peptide Interactions: Possible Ramifications for Vaccine Design (1989) (2)
The Molecular Organization of Gonococcal Pili (1985) (2)
Prediction of peptide affinity to HLA DR molecules. (1995) (2)
Monoclonal antipeptide antibodies against amino acid residues 1101-1106 of human C4 distinguish C4A from C4B. (1991) (2)
Prediction of peptide affinity to HLA DRB1*0401. (1995) (1)
The ternary complex: T cell receptor, MHC protein, and immunogenic peptide. (1990) (1)
Do amyloid fibrils induce inflammation, or does inflammation generate amyloid fibrils? (2022) (1)
Mechanistic Insights into Guanidinium-Rich Transporters Entering Cells (2006) (1)
Prediction and identification of bacterial and parasitic T-cell antigens and determinants. (1990) (1)
Response to Comment on “Chaperone Activity of α B-Crystallin Is Responsible for Its Incorrect Assignment as an Autoantigen in Multiple Sclerosis” (2011) (1)
ARGININE POLYMERS INHIBIT GRAFT CORONARY ARTERY DISEASE FOLLOWING CARDIAC TRANSPLANTATION.: Abstract# 726 (2000) (0)
Amyloid Fibril-Forming Hexapeptides Modulate The Immune Response And Reduce Symptoms In An Animal Model Of Multiple Sclerosis (S14.002) (2014) (0)
Alleight unassigned reading frames ofmouse mitochondrial DNA areexpressed (1984) (0)
Peptides Derived From HLA-A2 Modulate Lysis by HLA-A2-Specific Cytotoxic T Lymphocytes (1989) (0)
Myelin peptide moieties and the use of forms related to autoimmune diseases methods (1996) (0)
Variant and Mutant HLA-A2 Molecules Affect Recognition of Influenza Matrix Peptide 56–68 by Cytotoxic T Lymphocytes (1989) (0)
Compositions et methodes de traitement de maladies (2005) (0)
Table of Contents (1991) (0)
Recognition of Viral Antigens by Cytotoxic T Lymphocytes (1989) (0)
PILl OF NEISSER (2003) (0)
Rules for the Presentation of Peptides by Class II Molecules of the Major Histocompatibility Complex (1993) (0)
Correction (1988) (0)
Compositions for multiple sclerosis and its treatment (1997) (0)
1023: EXPLORING THE ANTI-INFLAMMATORY EFFECTS OF THE AMYLOIDOGENIC HEXAPEPTIDE, AMYLIN28-33, IN SEPSIS (2015) (0)
Enhanced binding of peptide to HLA-DR1 by point substitution (1992) (0)
Apicomplexan pathways, inhibitors, and drug delivery (2005) (0)
Janus Faces of Amyloid Proteins in Neuroinflammation (2014) (0)
Studies of MHC Class II Restricted Antigen Recognition by Human T Cell Clones Using Transfectant Antigen-Presenting Cells (APC) (1989) (0)
Peptide-mediated modulation of T-cell allorecognition ( antigen presentation / HLA class I major histocompatibility complex / influenza hemagglutinin ) (0)
Structure of the heavy chain of the H-2 Kk histocompatibility antigen ( CNBr fragments / radiochemical sequence analyses / tunicamycin / phosphorylation ) (0)
1784 MONOCLONAL ANTIBODIES TO GONOCOCCAL PILl TABLE I Amino Acid Sequences of the Synthetic Oligopeptides and their Corresponding Location in MS 11 Pilin (2003) (0)
Purification of Complexes between Peptide Antigens and Class II Major Histocompatibility Complex Antigens Using Biotinylated Peptides (1989) (0)
Positioning of a peptide in the cleft of HLA-A 2 by complementing amino acid changes FRANCE (0)
Table of Contents (1987) (0)
Microsoft Word-JBC resubmittal Dec 28.docx (2011) (0)
Cell recognition of a HLA-DR1-peptide complex: Analysis of an influenza hemagglutinin peptide in the antigen combining site (1990) (0)
Antibodies to peptides correspondi gonococcal pilins block bacterial ad (immunogenicity/synthetic peptides/reverse turns/gonococcal vaccini (2016) (0)
T.130. Small Heat Shock Proteins as Novel Therapeutic Treatments for Autoimmune Diseases (2009) (0)
Immune Responses of Patients with Myasthenia Gravis to Peptides Representing Different Regions of the Human Acetylcholine Receptor (1989) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jonathan B. Rothbard?

Jonathan B. Rothbard is affiliated with the following schools:

Jonathan B. Rothbard's Academic­Influence.com Rankings

Jonathan B. Rothbard's Degrees

Why Is Jonathan B. Rothbard Influential?

Jonathan B. Rothbard's Published Works

Published Works

What Schools Are Affiliated With Jonathan B. Rothbard?

Jonathan B. Rothbard's AcademicInfluence.com Rankings